Sector
PharmaceuticalsOpen
₹16.66Prev. Close
₹16.91Turnover(Lac.)
₹4.62Day's High
₹18.5Day's Low
₹16.352 Week's High
₹25.7552 Week's Low
₹14.44Book Value
₹8.84Face Value
₹10Mkt Cap (₹ Cr.)
17.56P/E
0EPS
0.02Divi. Yield
021 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
4 Sep 2023
12:00 AM
AGM
Announcement Date: 04 Sep, 2023
8 Sep 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 10.1 | 10.1 | 10.1 | 10.1 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -1.2 | 1.42 | 1.06 | 0.97 |
Net Worth | 8.9 | 11.52 | 11.16 | 11.07 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 0.97 | 1.42 | 0.5 | 0.37 |
yoy growth (%) | -31.43 | 182.32 | 34.45 | 68.17 |
Raw materials | -0.42 | -0.62 | -0.4 | -0.26 |
As % of sales | 43.52 | 43.64 | 80.76 | 70.5 |
Employee costs | -0.19 | -0.32 | -0.24 | -0.15 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0.1 | 0.16 | 0.18 | -0.18 |
Depreciation | -0.04 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | -0.14 | 0.52 | 2.48 | -0.14 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -31.43 | 182.32 | 34.45 | 68.17 |
Op profit growth | -90.17 | -135.58 | 140.45 | -84.6 |
EBIT growth | -29.37 | -8.16 | -198.91 | -85.56 |
Net profit growth | -42.73 | -7.89 | -198.91 | -85.56 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 35.88 | 45.57 | 65.32 | 55.56 | 23.99 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 35.88 | 45.57 | 65.32 | 55.56 | 23.99 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.42 | 7.37 | 7.67 | 0.65 | 0.27 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.45 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,520.1 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.15 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.6 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,639.05 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director
Sushant Mohan Lal
Independent Director
G Venkateswara Rao
Company Sec. & Compli. Officer
Megha Agarwal
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Decipher Labs Ltd
Summary
Decipher Labs Ltd. (formerly known as Combat Drugs Ltd) was incorporated as a Private Limited Company in September, 1986 and was converted into a Public Limited Company in Jun.92. The company was promoted by Suchit Mohan Lal and Ajay Karan. The Company is a professionally managed, well established, diversified Public Limited Company, engaged in the Manufacture & Marketing of Pharmaceuticals and allied products and services and providing Services and key Solutions in Information Technology Industry. Since inception, the Company has been manufacturing & marketing its branded formulations and custom manufacturing for various companies besides supplies of various Bulk drugs, chemicals and Finished Formulations. During the years of operations, it has garnered a reputation as a quality provider in the Pharmaceutical industry and the Products marketed by the Company have been well accepted by the Trade and Medical Fraternity across India.?The Company also diversified interest in the field on Information Technology and has developed a name for itself as a key solution provider in the field of associated technologies. It expanded by reviving the Information Technology wing and started dealing and reviving its associations into the Information Technology Industry. To increase presence in the Information Technology segment, the Company acquired Decipher Software Solutions LLC in USA to add good volumes to the overall turnover and Profits of the Company. The Company came out with a publi
Read More
What is the Decipher Labs Ltd share price today?
The Decipher Labs Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹17.39 today.
What is the Market Cap of Decipher Labs Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Decipher Labs Ltd is ₹17.56 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Decipher Labs Ltd?
The PE and PB ratios of Decipher Labs Ltd is 0 and 1.91 as of 22 Jul ‘24
What is the 52 Week High and Low of Decipher Labs Ltd?
The 52-week high/low is the highest and lowest price at which a Decipher Labs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Decipher Labs Ltd is ₹14.44 and ₹25.75 as of 22 Jul ‘24
What is the CAGR of Decipher Labs Ltd?
Decipher Labs Ltd's CAGR for 5 Years at -8.21%, 3 Years at -22.90%, 1 Year at -0.47%, 6 Month at -18.11%, 3 Month at 6.82% and 1 Month at -11.19%.
What is the shareholding pattern of Decipher Labs Ltd?
The shareholding pattern of Decipher Labs Ltd is as follows:
Promoters - 16.43 %
Institutions - 0.00 %
Public - 83.57 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
